CIK 0001664710 · Non-accelerated filer<br>Smaller reporting company
Keros Therapeutics, Inc.
Sign in to watch- Ticker
- KROS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811173868
- Phone
- 617-314-6297
- Business address
- 1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $10,270
- in 1 filing
- Open-market sales, last 90 days
- $101,136
- in 4 filings, $6K under 10b5-1 plans
Net −$90,866. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-20 | ADAR1 Capital Management, LLC 10% owner | Option exercise · Put Option (right to sell) | −2 | 0 | ||
| 2025-06-04 | Knowles Julius Director | Grant or award | +5,250 | 6,441 | ||
| 2025-06-04 | Knowles Julius Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2025-06-04 | GORDON CARL L Director | Grant or award | +5,250 | 5,250 | ||
| 2025-06-04 | GORDON CARL L Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2025-06-04 | Kariv Tomer Director | Grant or award | +5,250 | 5,250 | ||
| 2025-06-04 | Kariv Tomer Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2025-06-04 | Nussbaum Ran Director | Grant or award | +5,250 | 5,250 | ||
| 2025-06-04 | Nussbaum Ran Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2025-06-04 | Seth Alpna Director | Grant or award | +5,250 | 5,250 | ||
| 2025-06-04 | Seth Alpna Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2025-06-04 | GRAY MARY ANN Director | Grant or award | +5,250 | 5,250 | ||
| 2025-06-04 | GRAY MARY ANN Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2025-06-04 | Farzan Nima Director | Grant or award | +5,250 | 5,250 | ||
| 2025-06-04 | Farzan Nima Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2025-06-04 | BIENAIME JEAN JACQUES Director | Grant or award | +5,250 | 5,450 | ||
| 2025-06-04 | BIENAIME JEAN JACQUES Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2025-05-16 | ADAR1 Capital Management, LLC 10% owner | Other disposition · Put Option (obligation to buy) | −300 | 0 | ||
| 2025-05-16 | ADAR1 Capital Management, LLC 10% owner | Other disposition · Put Option (obligation to buy) | −836 | 0 | ||
| 2025-05-16 | ADAR1 Capital Management, LLC 10% owner | Other disposition · Put Option (obligation to buy) | −178 | 0 |
Page 4 of 9 · 173 trades